Skip to main content

Eva Polverino

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Eva Polverino

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

Contribución de la disfunción de CFTR al desarrollo y agresividad del cáncer de páncreas. Estimulación del crecimiento tumoral y metástasis por células estrelladas carentes de CFTR.

IP: Francesc Xavier Molero Richard
Collaborators: Laura Campderros Traver, Contribución de la disfunción de CFTR al desarrollo y agresividad del cáncer de páncreas. Estimulación del crecimiento tumoral y, Eva Polverino
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI22/00887
Duration: 01/01/2023 - 31/12/2025

Grup de Recerca en Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Sergi Martí Beltran, Marta Vicenta Arjona Perís, Christian Eduardo Romero Mesones, Maria Angeles Jiménez Fuentes, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Álvarez Fernandez, Victor Monforte Torres, Odile Romero Santo-Tomas, Miriam Barrecheguren Fernández, David Clofent Alarcón, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Almudena Felipe Montiel, Gerard Orriols Torras, Victoria Ruiz De Miguel, Meritxell Boada Perez, David Espejo Castellanos, Manuel López Meseguer, David Soler Segovia, Susana Gómez Olles, Cristina Esquinas López, Berta Saez Gimenez, Grup de Recerca en Pneumologia, Iñigo Ojanguren Arranz, Eva Polverino , Alexa Gabriela Nuñez Dubon, Letizia Traversi
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 0.01
Reference: 2021 SGR 00788
Duration: 01/01/2022 - 31/12/2024

ECRAID-Base (European Clinical Research Alliance for Infectious Diseases) H2020-SC1-2020-Single-Stage-RTD Grant agreement ID: 965313

IP: Eva Polverino
Collaborators: Ianire Gallego Amaro
Funding agency: EUROPEAN COMMISSION
Funding: 21875
Reference: ECRAID-H2020-SC1-BHC-35-2020
Duration: 01/03/2021 - 28/02/2026

COVID-19, PERFIL INMUNOLÓGICO DE RIESGO

IP: Ricardo Pujol Borrell
Collaborators: Manuel Hernández González, Mónica Martínez Gallo, Moisés Labrador Horrillo, Gema Codina Grau, Albert Blanco Grau, Andres Antón Pagarolas, Antonio Álvarez Fernandez, Nuria Fernández Hidalgo, Roser Ferrer Costa, Esteve Ribera Pascuet, Juan Carlos Ruiz Rodriguez, Jaume Ferrer Sancho, Anna Suy Franch, Pere Soler Palacín, Albert Selva O'Callaghan, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Marta Miarons Font , Daniel Alvarez De la Sierra, Andrea Martín Nalda, Eva Polverino , Romina Dieli Crimi, Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 229000
Reference: COV20/00416
Duration: 08/05/2020 - 08/11/2021

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Thaïs Murciano Carrillo

Thaïs Murciano Carrillo

Childhood Cancer and Blood Disorders
Read more
Albert Igual Barceló

Albert Igual Barceló

Senior researcher
Read more
Juan Ignacio Esteban Mur

Juan Ignacio Esteban Mur

Main researcher
Liver Diseases
Read more
Angel Manuel Lorente Cobo

Angel Manuel Lorente Cobo

Auxiliar Tècnic/a Recerca
Experimental Surgery Unit (ESU)
Preclinical Core Facilities
Core Facilities Area
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.